25.78
Omnicell Inc stock is traded at $25.78, with a volume of 861.82K.
It is up +1.54% in the last 24 hours and down -21.14% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$25.39
Open:
$25.7
24h Volume:
861.82K
Relative Volume:
1.37
Market Cap:
$1.46B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-56.04
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
-17.27%
1M Performance:
-21.14%
6M Performance:
-48.58%
1Y Performance:
-14.78%
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
OMCL
Omnicell Inc
|
25.78 | 1.46B | 1.08B | -20.76M | 151.63M | -0.46 |
![]()
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-03-24 | Initiated | Barclays | Underweight |
Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Sep-26-23 | Reiterated | Wells Fargo | Underweight |
Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-09-22 | Initiated | BofA Securities | Buy |
Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
Dec-06-21 | Resumed | Wells Fargo | Overweight |
Jun-09-21 | Initiated | JP Morgan | Neutral |
May-24-21 | Initiated | BTIG Research | Buy |
Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-08-20 | Initiated | Berenberg | Buy |
Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Jul-07-20 | Initiated | Stephens | Overweight |
Feb-07-20 | Reiterated | Dougherty & Company | Buy |
Nov-21-19 | Reiterated | Dougherty & Company | Buy |
Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
Mar-07-19 | Reiterated | Dougherty & Company | Buy |
Jun-29-18 | Resumed | The Benchmark Company | Buy |
Sep-05-17 | Reiterated | The Benchmark Company | Buy |
Jul-28-17 | Reiterated | Dougherty & Company | Buy |
Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
Jan-19-17 | Initiated | Dougherty & Company | Buy |
Dec-06-16 | Reiterated | The Benchmark Company | Buy |
Jul-07-16 | Reiterated | FBR Capital | Outperform |
Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
Jan-07-16 | Initiated | The Benchmark Company | Buy |
Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
Oct-30-15 | Reiterated | FBR Capital | Outperform |
Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Remote Dispenser Market Grows with Automation Trends - openPR.com
US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results - simplywall.st
Healthcare Robotics Market Generated Opportunities, Future - openPR.com
Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q1 2025 Earnings Call Transcript - Insider Monkey
Benchmark cuts Omnicell stock price target to $40 from $62 By Investing.com - Investing.com South Africa
Beyond The Numbers: 4 Analysts Discuss Omnicell Stock - Benzinga
OMNICELL, INC. SEC 10-Q Report - TradingView
Benchmark cuts Omnicell stock price target to $40 from $62 - Investing.com Australia
Omnicell: Facing New Headwinds (NASDAQ:OMCL) - Seeking Alpha
Benchmark Lowers Price Target for Omnicell (OMCL) to $40 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Price Target Lowered by Wells Fargo | OMCL Stock News - GuruFocus
Omnicell (OMCL) Price Target Reduced Amid Tariff Concerns | OMCL Stock News - GuruFocus
Omnicell (OMCL) Price Target Reduced by BofA Analyst Amid Tariff Concerns | OMCL Stock News - GuruFocus
Omnicell (OMCL) Price Target Slashed Amid Tariff Concerns | OMCL Stock News - GuruFocus
Omnicell First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Omnicell Reports Strong Q1 2025 Financial Results - TipRanks
Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue ... - Yahoo Finance
Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue Growth - GuruFocus
Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue ... By GuruFocus - Investing.com Canada
Omnicell Q1 2025 Earnings Call Transcript - MarketBeat
Omnicell outlines $40M tariff impact and anticipates $1.105B-$1.155B revenue for 2025 - MSN
Omnicell: Q1 Earnings Snapshot - Midland Daily News
Why Omnicell (OMCL) Shares Are Trading Lower Today - Yahoo Finance
Earnings call transcript: Omnicell Q1 2025 beats EPS forecasts, stock drops - Investing.com Nigeria
Relative Strength Alert For Omnicell - Nasdaq
Omnicell falls after 2025 profit forecast cut - TradingView
Omnicell Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Omnicell Announces First Quarter 2025 Results - 01net
Omnicell (OMCL) Beats Q1 Expectations, Revises 2025 Guidance - GuruFocus
Omnicell Q1 2025 slides: revenue up 10%, recurring revenue reaches 56% of total - Investing.com Australia
Omnicell Q1 2025 slides: revenue up 10%, recurring revenue reaches 56% of total By Investing.com - Investing.com South Africa
Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Omnicell (OMCL) Adjusts 2025 Guidance Amid Cost Concerns | OMCL Stock News - GuruFocus
Omnicell (OMCL) Surpasses Q1 Revenue Expectations with $270M | O - GuruFocus
Omnicell Inc Surpasses Q1 2025 Estimates with $0.26 EPS and $270 Million Revenue - GuruFocus
Omnicell Announces First Quarter 2025 Results | OMCL Stock News - GuruFocus
Omnicell shares tumble on weak guidance despite Q1 beat By Investing.com - Investing.com South Africa
Omnicell shares tumble on weak guidance despite Q1 beat - Investing.com Australia
(OMCL) OMNICELL INC. Forecasts Fiscal Year 2025 Adjusted EPS Range $1.00$1.65 - marketscreener.com
(OMCL) OMNICELL INC. Forecasts Q2 Adjusted EPS Range $0.19$0.32 - marketscreener.com
Earnings Flash (OMCL) OMNICELL INC. Reports Q1 Revenue $269.7M, vs. FactSet Est of $259.9M - marketscreener.com
Omnicell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Multifunctional Intravenous Drug Dispensing Robot Market - openPR.com
Central Fill Pharmacy Automation Market Is Booming So - openPR.com
Central Fill Pharmacy Automation Market Set to Witness - openPR.com
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term - Yahoo Finance
Is The Market Rewarding Omnicell, Inc. (NASDAQ:OMCL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - simplywall.st
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omnicell Inc Stock (OMCL) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):